The use of molecular line probe assays for the detection of resistance to second-line anti-tuberculosis drugs: policy guidance
This document provides a summary of the evidence and recommendations for the use of SL-LPA for the detection of mutations associated with resistance to fluoroquinolones and SLID in patients with RR-TB and/or MDR-TB. The objectives of this policy guidance are to assess and compare the diagnostic accuracy ...
Tuberculose multirésistante/diagnostic, Antibiotiques antituberculeux/pharmacologie, Techniques de sonde moléculaire, Tests de sensibilité microbienne, Fluoroquinolones/usage thérapeutique, Résistance bactérienne aux médicaments/génétique, Génotype, Mutation, Tuberculose multirésistante/génétique, Mycobacterium tuberculosis/effets des médicaments et des substances chimiques, Mycobacterium tuberculosis/génétique